phosphorylethanolamine has been researched along with Atrophy, Muscular, Peroneal in 1 studies
phosphorylethanolamine: RN given refers to parent cpd; structure
O-phosphoethanolamine : The ethanolamine mono-ester of phosphoric acid, and a metabolite of phospholipid metabolism. This phosphomonoester shows strong structural similarity to the inhibitory neurotransmitter GABA, and is decreased in post-mortem Alzheimer's disease brain.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ho, AK | 1 |
| Wagstaff, JL | 1 |
| Manna, PT | 1 |
| Wartosch, L | 1 |
| Qamar, S | 1 |
| Garman, EF | 1 |
| Freund, SM | 1 |
| Roberts, RC | 1 |
1 other study available for phosphorylethanolamine and Atrophy, Muscular, Peroneal
| Article | Year |
|---|---|
The topology, structure and PE interaction of LITAF underpin a Charcot-Marie-Tooth disease type 1C.
Topics: Amino Acid Sequence; Carrier Proteins; Cell Line; Charcot-Marie-Tooth Disease; Ethanolamines; HeLa C | 2016 |